Comparative Effectiveness, Value-Based Medicine® and Pharmaceutical Valuation

1. Brown MM, Brown GC, Sharma S. Evidence-Based to Value-Based Medicine, Chicago, AMA (American Medical Association) Press, 2005, pp 1-324.

2. Brown GC, Brown MM. Healthcare economic analyses. Evidence-based medicine and beyond. RETINA 2004;24:139-146.

3. Brown GC, Brown MM, Sharma S, Brown H, Smithen L, Leeser D, Beauchamp G. Value-based medicine and ophthalmology. An appraisal of cost-utility analyses. Trans Am Ophthalmol Soc 2004;102:177-185.

4. Brown GC, Brown MM, Sharma S. Value-based medicine: evidence-based medicine and beyond. Ocul Immunol Inflamm 2003;11:157-170.

5. Brown MM, Brown GC, Sharma S, Landy J. Health care economic analyses and value-based medicine. Surv Ophthalmol 2003;48:204-223.

6. Brown GC, Brown MM, Sharma S, Brown H, Smithen L, Leeser D, Beauchamp G. Value-based medicine and ophthalmology. An appraisal of cost-utility analyses. Trans Am Ophthalmol Soc 2004;102:177-185.

7. Brown GC, Brown MM, Sharma S. Value-based medicine: evidence-based medicine and beyond. Ocul Immunol Inflamm 2003;11:157-170.

8. Brown GC, Brown MM, Brown H, Kindermann S, Sharma S. The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration. Trans Am Ophthalmol Soc 2007;105:160-9.

9. Brown MM, Brown GC. Value-based medicine and pharmacoeconomics. In Nguyen QD, Rodrigues EB, Farah ME and Mieler VF. Retinal Pharmacotherapy, New York, Elsevier, 2008, Chapter 55.

10. Busbee BG, Brown GC, Brown MM. Value-based medicine: a new paradigm to evaluate treatments for vitreoretinal diseases and other medical interventions. Int Ophthalmol Clin. 2004 Fall;44(4):155-72.

11. Brown MM, Brown GC, Sharma S. Value-based medicine. A paradigm for the 21st century. In Quillen DA (ed) Current Concepts in Ophthalmology Harrisburg, Pennsylvania Academy of Ophthalmology 2002;10:7-11.

12. Altersitz K. Interview with Gary C. Brown, MD, MBA

    “Sugeon: System of value-based medicine demands physician support. standardized approach to evaluating various ophthalmologica treatments demonstrates their inherent value to long-term quality of life.”

    Ocular Surgery News 208;26:3-4.Natalone R. AMD Treatment Trends Call Attention to Cost/Benefit Considerations. Retinal Physician, Jan/Feb, 2006, p 53-57.

13. Brown MM, Brown GC. Comparative effectiveness and translational medicine. Evidence-Based Ophthalmology 2008;9:11-13.

14. Brown MM, Brown GC. Regulations must be cost-effective. The Record, Sunday, December 24, 2000, pA22.

15. Brown MM, Brown GC. Will Disruptive Innovations Cure Health Care? Harvard Business Review 2001:79(2):151.

16. Brown MM, Brown GC. Health care—could be our best bargain after all. Evidence-Based Eye Care 2000;1(4):198-199.

17. Brown GC, Brown MM, Sharma S. Cost-utility analysis. Ann Int Med 2001;134:625-626.

18. Brown GC, Brown MM, Sharma S. Cost-effective analysis and ocular disease. JAMA 2000;284(4):428.

19. Brown GC, Brown MM, Sharma S. Analysis of costs. Arch Ophthalmol 2000;118:444.

20. Brown MM, Brown GC, Sharma S. Value-based medicine. Evidence-Based Eye Care 2002;3(1):8-9.

21. Brown MM, Brown GC. Outcome of corneal transplantation. Value-based health care. Br J Ophthalmol 2002;86:2-3.

22. Brown GC. One eye versus two. A value-based approach. Curr Opin Ophthalmol 2004;15:165-166.

23. Brown MM, Brown GC. Combine “the compassion of medicine with that fiscal responsibility the American public expects”. Am Med News 1999; 42:35-36.

24. Brown GC, Brown MM. Conventional medicine. Phila Inquirer, January 24, 1999, p E6.

25. Brown MM, Brown GC, Kertes, P. Value-based medicine analysis. Cost-utility standards. Evidence-Based Ophthalmology 2008;9:136-141.

26. Brown GC, Brown MM, Kertes P. Value-based medicine, Cost-utility analysis Direct versus societal costs. Evidence-Based Ophthalmology 2008;9:63-69.

27. Brown MM, Brown GC, Sharma S, Roth Z, Campanella J, Beauchamp G. The burden of age-related macular degeneration. A value-based analysis. Curr Opin Ophthalmol 2006;17:257-266.

28. Brown MM, Brown GC, Sharma S. Value-Based Medicine. A paradigm for quality pharmaceutical care. Drug Benefit Trends 2006;18:285-289.